Organovo Provides Market Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/29/2026
- S&P 500 ends higher as investors await tech earnings
- NVIDIA’s rising CDS the talk of Wall Street amid circular financing fears
- Market watchers weigh chances of a surprise Fed rate hike tomorrow
- U.S. chip stocks extend losses on AI financing, China competition fears
- Tesla to buy power from Arizona solar project
- Visa (V) To Cut 7% Of Its Workforce, Totaling About 2,600 Jobs - Bloomberg
- HF Sinclair plans to spin off lubricants unit, close Canadian refinery
- S&P 500 ends higher as investors await tech earnings
- NVIDIA’s rising CDS the talk of Wall Street amid circular financing fears
- SK Hynix's record profit misses forecasts, shares slump 10% despite robust AI chip demand
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- After-Hours Stock Movers: GOOGL, TSLA, NOW, IBM, TXN, MOH, URI
- After-Hours Stock Movers: SMCI, OKLO, XE, PEGA, CLDX, ALK
Organovo (ONVO) Updates Investor FAQ; Addresses Negative Market Commentary, Filing of Stock Shelf
March 13, 2015 10:35 AM EDTOrganovo Holdings (AMEX: ONVO) is positive Friday following a update on the current and expected market for its products, as well as financial positioning of the company. That announcement can be read here.
In addition, Organovo also updated the frequently asked questions (FAQ) portion of its website. The following are notable updates since the last update made on May 15,... More
Organovo (ONVO) Updates on Performance, Opportunities; Sees $100M+ Market for exVive3D
March 13, 2015 8:15 AM EDTOrganovo Holdings, Inc. (AMEX: ONVO), is providing the following market update:
Organovo remains extremely excited about the early commercial success of our exVive3D Human Liver Tissue and we continue to believe it has a strong commercial future in front of it. Nothing has changed from the Company's perspective, nor are we in possession of any new information that would dampen our optimism about the future of our exVive3D Human Liver Tissue or the... More
